Liquidia Technologies

Entity type image
Type: Company
Name: Liquidia Technologies
First reported May 21 2013 - Updated 7 hours ago - 6 reports

Liquidia Technologies Announces Extension of Collaboration with PATH

Company’s virtual conjugate vaccine program shows promise. ... [Published Technology Networks - 7 hours ago]
First reported May 17 2013 - Updated May 17 2013 - 1 reports

Liquidia Technologies Presents Preclinical Ophthalmology Data at 2013 ARVO Annual Meeting

(NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- Liquidia Technologies announced the presentation of data from two preclinical studies at the 2013 Association for Research in Vision and Ophthalmology (ARVO) annual meeting. The ARVO ... [Published NewsRX - May 17 2013]
First reported May 15 2013 - Updated May 15 2013 - 1 reports

Liquidia Technologies Presents Preclinical Ophthalmology Dat. . .

Liquidia Technologies Presents Preclinical Ophthalmology Data at 2013 ARVO Annual MeetingLiquidia TechnologiesNewsRx.comBy a News Reporter-Staff News Editor at Vaccine Weekly -- Liquidia Technologies announced the presentation of data from two preclinical ... [Published Equities.com - May 15 2013]
First reported May 09 2013 - Updated May 09 2013 - 1 reports

Liquidia Technologies to Present at Association for Research in Vision and Ophthalmology Meeting

Liquidia Technologies announced the presentation of data from two preclinical studies at the 2013 Association for Research in Vision and Ophthalmology annual meeting.In a release, the Company noted that the two poster presentations are:Precisely Engineered ... [Published Individual.com - May 09 2013]
First reported May 08 2013 - Updated May 08 2013 - 1 reports

Liquidia Announces Plan to Form Ophthalmology Company to Sup. . .

Liquidia Announces Plan to Form Ophthalmology Company to Support Product Development StrategyLiquidia TechnologiesNewsRx.comBy a News Reporter-Staff News Editor at Biotech Week -- Liquidia Technologies announced its intent to form a new ophthalmology-focused ... [Published Equities.com - May 08 2013]
First reported May 06 2013 - Updated May 07 2013 - 7 reports

Data on Liquidia’s Nanoparticle Technology for Ophthalmic Suspension Formulations to be Presented at ARVO 2013

Liquidia Technologies today announced the presentation of data from two preclinical studies at the 2013 Association for Research in Vision and Ophthalmology (ARVO) annual meeting.The ARVO annual meeting is the largest and most respected eye and vision ... [Published Azonano - May 07 2013]
First reported May 03 2013 - Updated May 03 2013 - 1 reports

Liquidia plans to set up new ophthalmology company

Liquidia Technologies is planning to set up a new ophthalmology-focused company to manufacture products that address the unmet needs, growth therapeutic areas and to maximize the return for its investors. ... [Published Medical Devices Business Review - May 03 2013]
First reported May 02 2013 - Updated May 02 2013 - 1 reports

New company springs from nanotech Liquidia

Nanotechnology firm Liquidia Technologies is spinning out a new ophthalmology-focused company, building on the success of a recent partnership with GlaxoSmithKline (NYSE: GSK).Last year, an agreement with GSK regarding Liquidia’s vaccine and pulmonary ... [Published Triangle Business Journal - May 02 2013]

Quotes

...to the development of very promising therapeutics in high growth areas," said Neal Fowler, Chief Executive Officer at Liquidia Technologies. "Developing a structure that allows for the creation and financing of new companies is a great fit for the ophthalmology focused business and is a structure we will continue to consider with other assets and therapeutic areas as we go forward."
"We have been hearing about the promise of nanomedicine for a long time, but it is now really starting to move" said Dan Peer, who runs a nanomedicine laboratory at Tel Aviv University
The drugs are based on  NanoViricides " biomimetic technology, which mimicks the natural sialic acid receptors for the influenza virus on the surface of a nanoviricide polymeric micelle. The company noted that all flu viruses bind to the sialic acid receptors, even if they rapidly mutate.  "
Presentation topics include: "The Art of Fundus Photo Interpretations,” “Glaucoma Surgery: Today’s Solution and New Promising Alternatives,” “Glaucoma Treatment: The Unexpected,” “SLT vs. Meds: Who’s on First?” “Glaucoma: Is Cataract Surgery Always the Answer?” “Narrow Angles: Is LPI Enough?” “New Visual Function Testing in Glaucoma,” “Complexities Encountered with Cataract Surgery in Glaucoma Patients,” “Should Cataract Surgery Be Considered a Glaucoma Procedure?” “Impact of Cultural Competence in Glaucoma,” “Myopia: The Next Glaucoma Epidemic?” “Glaucoma: Managing the Odds,” and “Health Care Reform: Winners and Losers – How Can I Be a Winner?”"

More Content

All (36) | News (22) | Reports (0) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (13)
sort by: Date | Relevance
Liquidia Technologies Announces Extension of Co... [Published Technology Networks - 7 hours ago]
Liquidia Technologies Inc. Announces Extension ... [Published BioSpace - May 21 2013]
Liquidia Technologies Announces Extension of Co... [Published BioMedReports - May 21 2013]
Liquidia Technologies Announces Extension of Co... [Published Yahoo! Finance - May 21 2013]
Liquidia Technologies Announces Extension of Co... [Published EON - May 21 2013]
Liquidia Technologies Announces Extension of Co... [Published Rock Hill Herald - May 21 2013]
Liquidia Technologies Announces Extension of Co... [Published EON Science - May 21 2013]
Liquidia Technologies Announces Extension of Co... [Published Business Wire Technology News - May 21 2013]
Liquidia Technologies Announces Extension of Co... [Published Business Wire Science: Science News - May 21 2013]
Liquidia Technologies Announces Extension of Co... [Published Business Wire Health News - May 21 2013]
Liquidia Technologies Presents Preclinical Opht... [Published NewsRX - May 17 2013]
Liquidia Technologies Presents Preclinical Opht... [Published Equities.com - May 15 2013]
Liquidia Technologies to Present at Association... [Published Individual.com - May 09 2013]
Liquidia Announces Plan to Form Ophthalmology C... [Published Equities.com - May 08 2013]
Data on Liquidia’s Nanoparticle Technology for ... [Published Azonano - May 07 2013]
Liquidia Technologies Presents Preclinical Opht... [Published SPi World News - May 06 2013]
Liquidia Technologies Presents Preclinical Opht... [Published Rock Hill Herald - May 06 2013]
Liquidia Technologies Presents Preclinical Opht... [Published CNBC - May 06 2013]
Liquidia Technologies Presents Preclinical Opht... [Published Yahoo! Finance - May 06 2013]
Liquidia Technologies Presents Preclinical Opht... [Published NewsBlaze - May 06 2013]
Liquidia Technologies Presents Preclinical Opht... [Published Zecco - May 06 2013]
Liquidia Technologies Presents Preclinical Opht... [Published Business Wire - May 06 2013]
Liquidia Technologies Presents Preclinical Opht... [Published Business Wire Technology News - May 06 2013]
Liquidia plans to set up new ophthalmology company [Published Medical Devices Business Review - May 03 2013]
Big drugmakers think small with nanomedicine deals [Published London South East - May 03 2013]
New company springs from nanotech Liquidia [Published Triangle Business Journal - May 02 2013]
Liquidia Announces Plan to Form Ophthalmology C... [Published Business Wire - May 02 2013]
Liquidia Announces Plan to Form Ophthalmology C... [Published Business Wire Technology News - May 02 2013]
Liquidia Announces Plan to Form Ophthalmology C... [Published Business Wire Health News - May 02 2013]
NanoViricides shares gain as it takes the lead ... [Published Proactiveinvestors United Kingdom website - Mar 06 2013]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
NanoViricides shares gain as it takes the lead ... [Published Proactiveinvestors United Kingdom website - Mar 06 2013]
NanoViricides  (OTCBB:NNVC) saw its shares surge over seven per cent Wednesday, after announcing that president Anil Diwan will lead section 1 of the Symposium on Nanomedicines: Charting a Roadmap to Commercialization, called “Designing Nanomedicines”. ...
1

Press Releases

sort by: Date | Relevance
Liquidia Technologies Announces Extension of Co... [Published EON Science - May 21 2013]
Liquidia Technologies Announces Extension of Co... [Published Business Wire Technology News - May 21 2013]
Liquidia Technologies Announces Extension of Co... [Published Business Wire Science: Science News - May 21 2013]
Liquidia Technologies Announces Extension of Co... [Published Business Wire Health News - May 21 2013]
Liquidia Technologies Presents Preclinical Opht... [Published Business Wire - May 06 2013]
1 2 3
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.